Combined Therapy With Avastin, a PAF Receptor Antagonist and a Lipid Mediator Inhibited Glioblastoma Tumor Growth

Glioblastoma multiforme (GBM) is an aggressive, highly proliferative, invasive brain tumor with a poor prognosis and low survival rate. The current standard of care for GBM is chemotherapy combined with radiation following surgical intervention, altogether with limited efficacy, since survival avera...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz Flores, Valerie A., Menghani, Hemant, Mukherjee, Pranab K., Marrero, Luis, Obenaus, Andre, Dang, Quan, Khoutorova, Larissa, Reid, Madigan M., Belayev, Ludmila, Bazan, Nicolas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498947/
https://www.ncbi.nlm.nih.gov/pubmed/34630114
http://dx.doi.org/10.3389/fphar.2021.746470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498947/
https://www.ncbi.nlm.nih.gov/pubmed/34630114
http://dx.doi.org/10.3389/fphar.2021.746470

Ejemplares similares